Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002009368-25-000004
Filing Date
2025-07-09
Accepted
2025-07-09 06:26:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2914
  Complete submission text file 0002009368-25-000004.txt   4272
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Subject) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 144 | Act: 33 | File No.: 001-38757 | Film No.: 251112226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45-55 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Shannon Elaine Mary (Reporting) CIK: 0002009368 (see all company filings)

Type: 144